BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36041490)

  • 1. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
    Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
    Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
    Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
    PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea.
    Bahk YY; Ahn SK; Lee J; Im JH; Yeom JS; Park S; Kwon J; Kan H; Kim M; Jang W; Kim TS
    Korean J Parasitol; 2021 Oct; 59(5):447-455. PubMed ID: 34724763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Gia Lai Province, Vietnam.
    Võ TC; Lê HG; Kang JM; Nguyễn ĐTD; Nguyễn TH; Yoo WG; Goo YK; Thi Minh Trinh N; Van Khanh C; Hong Quang H; Na BK
    Parasitol Int; 2024 Jun; 100():102868. PubMed ID: 38387679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
    Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
    Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
    PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
    Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
    PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
    Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
    BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
    Baird JK
    BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.